|
|
Article: MIV Therapeutics' Advanced Stent Coating Technologies Praised in Respected Germany-Based Investment Newsletter; Article Targeted to European Financial Community Features MIVT's Innovative Development Program.
- Article from:
- Business Wire
- Article date:
- December 23, 2005
CopyrightCOPYRIGHT 2005 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
VANCOUVER, British Columbia -- MIV Therapeutics, Inc. (OTCBB:MIVT) (FWB:MIV), a leading developer of new-generation biocompatible coatings and advanced drug delivery systems, has announced that the Company was the subject of an article in a recent issue of "Der Aktionar," an investment and finance periodical published in Germany, which praised the medical and marketplace potential of the Company's innovative drug-eluting stent technologies as well as its novel stroke-preventing devices.
The "Der Aktionar" article, "MIV Therapeutics - Forward-Looking Technology," praises the Company's pioneering proprietary technology program for the improvement of coronary stent ...